A randomized trial among women with heavy menstruation – impact of a decision aid on treatment outcomes and costs
Bibliographic Data
| ID | 19508932 |
|---|---|
| Authors | Sirkku Vuorma (Finnish Institute for Health and Welfare), Juha Teperi (Research Council of Finland), Anna-Mari Aalto (0000-0002-1287-1431, Research Council of Finland), Anna‐Mari Aalto, Ritva Hurskainen (Helsinki University Hospital), Erkki Kujansuu (Tampere University Hospital), Pekka Rissanen (0000-0003-0398-6250, Tampere University) |
| Year | 2004 |
| Volume | 7 |
| Issue | 4 |
| Pages | 327-337 |
| Publication date | 2004-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Health Expectations (JOURNAL) |
| Journal identifiers | ISSN: 1369-6513 • E-ISSN: 1369-7625 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1369-7625.2004.00297.x |
| PMID | 15544685 |
| OpenAlex | W2097874575 |
| Language | EN |
| Citations received | 1 |
| References cited | 12 |
Objective To evaluate the effects of a decision aid for menorrhagia on treatment outcomes and costs over a 12‐month follow‐up. Design Randomized trial and pre‐trial prospective cohort study. Setting and participants Gynaecology outpatient clinics in 14 Finnish hospitals, 363 (randomized trial) plus 206 (cohort study) patients with menorrhagia. Intervention A decision aid booklet explaining menorrhagia and treatment options, mailed to patients before their first clinic appointment. Main outcome measures Health related quality of life, psychological well‐being, menstrual symptoms, satisfaction with treatment outcome, use and cost of health care services. Results All study groups experienced overall improvement in health‐related quality of life, anxiety, and psychosomatic and menstrual symptoms, but not in sexual life. Treatment in the intervention group was more active than in the control group, with more frequent course of medication and less undecided treatments. However, there were no marked disparities in health outcomes, satisfaction with treatment outcome and costs. Total costs (including productivity loss) per woman because of menorrhagia over the 12‐month follow‐up were 2760€ and 3094€ in the intervention and control group, respectively ( P = 0.1). The pre‐trial group also had a significantly lower rate of uterus saving surgery compared with the control group, but no difference in costs because of menorrhagia treatment. Conclusion Despite some differences in treatment courses, a decision aid for menorrhagia in booklet form did not increase the use of health services or treatment costs, nor had it impact on health outcomes or satisfaction with outcome of treatment
Anxiety · Cohort · Menstruation · Patient satisfaction · Physical therapy · Psychiatry · Randomized controlled trial · Treatment and control groups · Medicine · Menopause: Health Impacts and Treatments · Nursing · Patient-Provider Communication in Healthcare · Uterine Myomas and Treatments · Internal Medicine · Surgery
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,11 |
| Citation span | 2017 - 2017 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |